Cipla’s Goa Unit Gets ‘Voluntary Action Indicated’ From USFDA

Cipla Ltd. announced on Thursday that the US Food and Drug Administration has classified the facility of its subsidiary, Medispray Laboratories Pvt, located in Kundaim, Goa, as ‘voluntary action indicated’ (VAI).
The inspection, conducted from January 14 to 20, resulted in a single observation. According to the company’s exchange filing, no immediate regulatory action is required.